Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05498792 |
Title | Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma |
Recruitment | Suspended |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Fox Chase Cancer Center |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |